D. H. Narayana

发表

KNOWLEDGE OF MOTHERS REGARDING IMMUNIZATION

Nandini R C, Prakruthi R A, D. H. Narayana, 2021 .

Assessing safety and immunogenicity of post-exposure prophylaxis following interchangeability of rabies vaccines in humans

D. H. Narayana, S. Madhusudana, A. Belludi, 2014, Human vaccines & immunotherapeutics.

A STUDY ON ANTENATAL MORBIDITIES IN A CORPORATION REFERRAL HOSPITAL, BANGALORE.

D. H. Narayana, Prakruthi R A Dr, C. NandiniR, 2021 .

Comparison of Safety and Immunogenicity of Purified Chick Embryo Cell Rabies Vaccine (PCECV) and Purified Vero Cell Rabies Vaccine (PVRV) Using the Thai Red Cross Intradermal Regimen at a Dose of 0.1 ML

V. Ravi, D. H. Narayana, S. Madhusudana, 2006, Human vaccines.

Evaluation of a one week intradermal regimen for rabies post-exposure prophylaxis: Results of a randomized, open label, active-controlled trial in healthy adult volunteers in India

D. H. Narayana, R. Holla, S. Madhusudana, 2012, Human Vaccines & Immunotherapeutics.

Assessing the relationship between antigenicity and immunogenicity of human rabies vaccines when administered by intradermal route

D. H. Narayana, M. Sudarshan, H. Ravish, 2010, Human vaccines.

Time interval for booster vaccination following reexposure to rabies in previously vaccinated subjects

D. H. Narayana, M. Sudarshan, H. S. Ravish, 2011 .

Epidemiology and prevention of animal bite and human rabies in a rural community-One health experiment

D. H. Narayana, Gangaboraiah, N. Masthi, 2014 .

Defining the volume of rabies immunoglobulins/ rabies monoclonal antibodies requirement for wound infiltration of category III animal exposures – an exploratory study

D. H. Narayana, M. Sudarshan, N. Kumari, 2021, Human vaccines & immunotherapeutics.

Safety and clinical efficacy of human rabies immunoglobulin in post exposure prophylaxis for category III animal exposures

D. H. Narayana, N. Kumari, Ravish S Haradanhalli, 2022, Human vaccines & immunotherapeutics.

Assessing the Relationship between Antigenecity and Immunogenecity of Human Rabies Vaccines: Results of a Meta-Analysis

D. H. Narayana, Gangaboraiah, S. Madhusudana, 2005 .

Safety of intradermal rabies vaccine as pre-exposure prophylaxis among veterinary students

D. H. Narayana, M. Phaneendra, H. Ravish, 2017 .

Boosting effect of purified chick embryo cell rabies vaccine using the intradermal route in persons previously immunized by the intramuscular route or vice versa.

D. H. Narayana, S. Madhusudana, B. J. Mahendra, 2006, The National medical journal of India.

Assessing the relationship between antigenicity and immunogenicity of human rabies vaccines. Results of a meta-analysis.

D. H. Narayana, Gangaboraiah, S. Madhusudana, 2005, Human vaccines.

Safety and immunogenicity of SII-NVX-CoV2373 (COVID-19 vaccine) in adults in a phase 2/3, observer-blind, randomised, controlled study

N. Gogtay, A. Kalantri, Anil Kumar, 2023, The Lancet Regional Health - Southeast Asia.

A DESCRIPTIVE STUDY ON CLASSIFICATION OF ADVERSE EVENTS FOLLOWING IMMUNIZATION AMONG INFANTS ATTENDING MATERNALAND CHILD HEALTH HOSPITAL, BANGALORE

Nandini R C, D. H. Narayana, Prakruthi A R, 2021 .